



Márcio Roberto Teixeira Nunes,* 
Lívia Carício Martins,* 
Sueli Guerreiro Rodrigues,* 
Jannifer Oliveira Chiang,* 
Raimunda do Socorro da Silva Azevedo,* 
Amelia P.A. Travassos da Rosa,† 
and Pedro Fernando da Costa Vasconcelos*
An Oropouche virus strain was isolated from a novel
host (Callithrix sp.) in Arinos, Minas Gerais State, south-
eastern Brazil. The virus was identified by complement fix-
ation test and confirmed by reverse transcription–
polymerase chain reaction. Phylogenetic analysis identified
this strain as a genotype III isolate previously recognized
only in Panama.
O
ropouche virus (OROV) is one of the most important
arthropodborne orthobunyaviruses (Bunyaviridae,
Orthobunyavirus) (1) that infect humans; it causes an acute
febrile illness called Oropouche fever (2). OROV was
originally reported in Trinidad in 1955, when the prototype
virus strain was isolated from the blood of a febrile patient
and from a pool of Coquillettidia venezuelensis mosqui-
toes (3). In Brazil, OROV was initially described in 1960,
when it was isolated from a sloth (Bradypus tridactylus)
captured near a forest area during the construction of the
Belém-Brasilia highway, and from a pool of Ochlerotatus
serratus mosquitoes captured nearby (4). More than one-
half million persons have been infected with OROV, which
makes this virus a public health threat in tropical and sub-
tropical areas of Central and South America (5). OROV
genome consists of 3 partite, single-stranded, negative-
sense RNAs, named large (L), medium (M), and small (S)
RNA. These RNAs are predicted to encode a large protein
(L: polymerase activity), viral surface glycoproteins (Gc
and Gn), and nonstructural NSM protein, as well as both
nucleocapsid (N) and NSS proteins (1). Complete
nucleotide sequences have been determined for all 3 RNA
segments (6–8), and previous studies of the molecular
biology of the N gene (SRNA) of 28 different OROV
strains indicated the existence of 3 genotypes, designated
I, II, and III (6).
The Study
A field study was conducted in the Arinos region,
Minas Gerais State, within the Grande Sertão Veredas
National Park, in February 2000. The park is located 90
km from Arinos city (15°54′S, 46°W) (Figure 1). The
Arinos region is part of the epizootic area of sylvatic yel-
low fever virus transmission, as previously reported (9). 
Using a biosafety cabinet class II B-2, we prepared sus-
pensions of viscera (liver, spleen, and kidney) obtained
from the monkey and then injected suckling mice by the
intracerebral route. Animals were observed daily and were
immediately collected when they died or showed signs of
disease. 
The virus was identified by using the complement fixa-
tion test (CF), performed according to a described tech-
nique (10). The BeAn 626990 antigen was tested against
different mice immune ascitic fluids (MIAFs) prepared for
a large number of arboviruses circulating in Brazil.
Molecular studies were conducted to confirm the sero-
logic results. Viral RNA was extracted by using the Trizol
reagent (Invitrogen, Carlsbad, CA, USA) technique as
described elsewhere, and the entire SRNA segment was
amplified, applying a 1-step reverse transcription–
polymerase chain reaction (RT-PCR) assay using the
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Figure 1. Map of the Arinos region, where the strain BeAN 626998
was isolated from a sylvatic monkey of the genus Callithrix. primers ORO N5 (5′ AAAGAGGATCCAATAATGTCA-
GAGTT CATTT 3′), ORO N3 (5′ GTG AAT TCC ACT
ATA TGC CAA TTC CGA ATT 3′), ORO 1A (5′ AGTA-
GTGTACTCCACTAT 3′) (6), ORONR 271 (5′ CGACTG-
GAACTGTGGGAAAT 3′), OROF593 (5′ AAGTCCT-
CCGGCAGAGGTAT 3′) and ORO2S (5′ AGTAGT GTG
GCT CCA CAT 3′) (6).
Amplicons were direct sequenced in an automated
sequencer (ABI 377, Applied Biosystems, Foster City, CA,
USA) using the Kit ABI PRISM Dye Terminator (Applied
Biosystems) by the dideoxyribonucleotide chain termina-
tor method (11). Nucleotide sequence obtained for the
strain BeAn 626990 were compared with 44 other OROV
N gene nucleotide sequences (AF164531–AF164558;
AY704559–AY704568; AY993909–AY993912), and phy-
logenetic trees were constructed by using both neighbor-
joining (NJ) (12) and maximum parsimony (MP) (13)
methods implemented in the Mega 2.1 (14) and PAUP 4.0
software, respectively. Bootstrap analyses with 1,000
replicates were used to place confidence values on group-
ings (15).
Mice injected with the strain BeAn 626990 showed
signs of disease 48–72 hours after intracerebral injection.
By CF, the suspension prepared from the brain of infected
mice showed positive reaction with the MIAF prepared for
the Brazilian prototype strain of OROV BeAn 19991
(>32/16). No cross-reactivity was observed with any other
MIAF prepared for the most common arboviruses current-
ly circulating in the region. The monkey strain was then
identified as OROV. 
The N gene was found to be 693 nt in length, while the
5′ and 3′ terminal regions showed 290 and 161 nt, respec-
tively. After the sequences assembly, accomplished by
using the Seq Man program (DNA STAR software pack-
age, DNASTAR Inc., Madison, WI, USA), the full-length
SRNA was determined (754 nt). The multiple sequence
analysis for the entire N gene of the strain BeAn 626990,
when Mega 2.1 software was used, showed homology with
different OROV strains previously sequenced
(92%–100%), as described (6).
Two overlapping open reading frames were determined.
One consisted of 693 nt (231 amino acids) and was predict-
ed to encode the N protein. The other open reading frame
consisted of 273 nt (91 amino acids) and was predicted to
encode the NSs proteins. Both coding regions were flanked
by 2 noncoding regions, located at the 5′ and 3′ terminals
that were 44 nt and 14 nt in length, respectively.
Phylogenetic analysis carried out for 44 OROV N gene
sequences (693 nt) with MP and NJ methods resulted in
trees with similar topology, even though slightly low boot-
strap values had been assigned for the MP consensus tree.
The NJ tree suggested that the strain BeAn 626990 was
more closely related to those included in genotype III.
Bootstrap support values of 100%, 74%, and 100% were
assigned for the genotypes I, II, and III, respectively
(Figure 2). 
Conclusions
The known OROV epidemic sites are restricted to trop-
ical areas of Central and South America, especially those
in the Amazon Basin. From 1961 to 1980, in Brazil,
OROV was reported in the northern state of Pará, where
the most important epidemics occurred in Belém, and
other regions of the state; hundred of thousands of persons
were affected. From 1980 to 2004, OROV spread to 5
other northern Brazilian states (Amazonas, Amapá, Acre,
Rondônia, and Tocantins) and 1 state in the northeast
(Maranhão), indicating, in a short period of time, a danger-
ous epidemic potential (Table) (5,6). 
The first isolation of OROV in the Arinos area in Minas
Gerais, Brazil, is of concern because this virus, under favor-
able ecologic conditions, can spread, and Oropouche fever
may develop in the local people, who are susceptible to
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Figure 2. Phylogeny of Oropouche virus (OROV) strains isolated
from different sources and periods by using the neighbor-joining
and maximum parsimony methods. Bootstrap values were
assigned over each internal branch nodes, and highest values
were indicated by continuous arrows showing the presence of at
least 3 lineages or genotypes (I, II, and III) of OROV. Bootstrap val-
ues for the 3 representative genotype clades are placed over each
respective branch node. The black arrow indicates the position of
the strain BeAn 626990 (Brazil 00) in the tree. The Aino N gene
nucleotide sequence was used as an outgroup to root the tree.
The scale bar represents 5% nucleotide sequence divergence.OROV. In fact, explosive Oropouche fever epidemics have
been reported in all of the following areas in Brazil:
Maranhão, Tocantins, Amazonas, Acre, Pará, and Rondônia
States. Such epidemics have also been reported in Iquitos
and Madre de Dios, Peru; and in Bejuco, Panama (5). 
Molecular studies (6) recognized 3 genotypes and sug-
gested the distribution for OROV in South and Central
America. The authors showed that in Brazil, genotype I,
the most widespread in the country, and genotype II, found
in Rondônia (a bordering state with Peru), and also in Para
state (M.R.T. Nunes, unpub. data) cocirculate. In Peru,
only genotype II has been identified. Genotype III has
been reported only in Panama, whereas in Trinidad, only
genotype I has been isolated (Table).
The genetic data obtained in this study, for the S seg-
ment of the strain BeAn 626990 (S: AY 117135), suggest
its genetic relationship with other OROV strains.
Phylogenetically, the monkey strain was shown to be more
closely related to genotype III OROV isolates (Figure 2)
and is the first report of genotype III in southeastern
Brazil. More importantly, OROV was detected for the first
time outside the known epidemiologic area for OROV
transmission in South America. Our findings also represent
the first report of OROV isolation from a monkey. 
The potential impact of OROV in Brazil can be better
assessed by viewing it in its demographic context. The
southeast is the most populated region in Brazil, compris-
ing urban areas such as the cities of Belo Horizonte, Rio de
Janeiro, and São Paulo. The entire region has intense intra-
and interregional migration, fostered by improved technol-
ogy and transportation, which may lead to increases in the
dissemination of both human and animal pathogens along
these areas. Therefore, further studies on the ecology, epi-
demiology, and molecular epidemiology of OROV are
needed, not only to improve knowledge about the epidemi-
ology of this arbovirus but also to find out if its epidemic
area is spreading outside the Amazon region and toward
the southeast and other populated regions in Brazil. This
situation is of particular concern because Oropouche fever
epidemics have been reported in several small villages in
the Brazilian Amazon region in 2003 and 2004
(Vasconcelos PFC, unpub. data). As a consequence, the
risk of spreading OROV to susceptible areas has increased
considerably in Brazil. More research and program devel-
opment are needed to control this potential epidemic
arboviral disease.
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